New Ray Medicine International Holding Limited announced that based on a preliminary review and analysis of the latest available unaudited consolidated management accounts of the Company, it is expected that the Group will record a net loss of not more than HKD 3 million for the year ended 31 December 2021 ("FY 2021") as compared to the net loss of approximately HKD 69.7 million recorded by the Group for the year ended 31 December 2020 ("FY 2020").